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ABSTRACT A reduction in pH induces the release of iron from transferrin in a process that involves a conformational change
in the protein from a closed to an open form. Experimental evidence suggests that there must be changes in the protonation
states of certain, as yet not clearly identified, residues in the protein accompanying this conformational change. Such changes
in protonation states of residues and the consequent changes in electrostatic interactions are assumed to play a large part
in the mechanism of release of iron from transferrin. Using the x-ray crystal structures of human ferri- and apo-lactoferrin, we
calculated the pKa values of the titratable residues in both the closed (iron-loaded) and open (iron-free) conformations with
a continuum electrostatic model. With the knowledge of a residue’s pKa value, its most probable protonation state at any
specified pH may be determined. The preliminary results presented here are in good agreement with the experimental
observation that the binding of ferric iron and the synergistic anion bicarbonate/carbonate results in the release of approx-
imately three H ions. It is suggested that the release of these three H ions may be accounted for, in most part, by the
deprotonation of the bicarbonate and residues Tyr-92, Lys-243, Lys-282, and Lys-285 together with the protonation of
residues Asp-217 and Lys-277.
INTRODUCTION
Computer simulation methods, when carefully allied with
experimental methods, provide tools for investigating elec-
trostatic interactions in proteins. When protein structural
stability and biological function are strongly correlated with
pH it is necessary to define the protonation states of titrat-
able residues as these may have a significant effect upon the
electrostatic interactions. As the identification of such a
state for a given residue is not always amenable to biochem-
ical or spectroscopic investigation and hydrogen atoms can-
not be located in a typical protein crystallographic study,
there is a role for computational calculations designed to
yield this information. As environmental factors affect the
pKa of a residue, a number of factors have to be taken into
account in their calculation, including the degree of solvent
exposure of a residue, the electrostatic potential of its en-
vironment in the protein, and the protonation states (and
thus net charges) of all other titrating residues in the protein.
Large shifts in the pKa values of residues have been re-
ported experimentally in a number of proteins and seem
quite common in enzyme active sites (e.g., Bartik et al.,
1994).
The most common approach to the calculation of pKa
values in protein molecules is through the use of the com-
putationally efficient continuum electrostatic model in
which solvent is represented as a region with a high dielec-
tric constant and the protein is represented as a cavity within
this region with a low dielectric constant. The electrostatic
potential around the protein may then be calculated using a
numerical solution of the linearized Poisson-Boltzmann
equation. This approach has been used to study a number of
proteins, including bovine erythrocyte Cu-Zn superoxide
dismutase (Klapper et al., 1986), hen egg-white lysozyme
(Bashford and Karplus, 1990),  repressor (Zacharias et al.,
1992), and yeast iso-1-ferricytochrome c (Zhou and Vijaya-
kumar, 1997).
We have chosen the continuum electrostatic approach to
study the transferrins, a family of glycoproteins that in-
cludes serum transferrin, ovotransferrin, and lactoferrin
(Baker, 1993). They consist of a single polypeptide chain of
680–700 amino acid residues. These show a high degree of
similarity, approximately 70% identity between lactoferrins
and 50–60% between lactoferrins and transferrins. Each of
the proteins also shows a striking twofold internal-sequence
homology, with typically 40% sequence identity between
the N-terminal and C-terminal halves of each molecule.
Given that stable half-molecule fragments can be prepared
and that each possesses an iron site with very similar spec-
troscopic characteristics, the clear implication is that the
two-sited transferrins have developed by gene duplication
from a one-iron, 40-kDa precursor molecule. Each Fe(III)
ion is bound together with a bicarbonate (HCO3) or, more
likely, carbonate (CO32) ion; neither is bound strongly, if at
all, in the absence of the other, but when taken together the
binding is extremely strong, with effective stability con-
stants of the order 1020 (Aasa et al., 1963). Nevertheless,
binding is reversible, both in vitro and in vivo, so mecha-
nisms must exist for the release of this tightly bound iron.
X-ray crystal structures of transferrins, including that of
human lactoferrin (Anderson et al., 1987), show that the
polypeptide chain is folded into two globular lobes, repre-
senting the N-terminal and C-terminal halves of the mole-
Received for publication 17 October 1997 and in final form 12 March
1998.
Address reprint requests to Dr. Julia Goodfellow, Department of Crystal-
lography, Birkbeck College, Malet Street, London WC1E 7HX, UK. Tel.:
44-171-631-6833; Fax: 44-171-631-6833; E-mail: j.goodfellow@mail.
cryst.bbk.ac.uk.
© 1998 by the Biophysical Society
0006-3495/98/06/2747/13 $2.00
2747Biophysical Journal Volume 74 June 1998 2747–2759
cule (residues 1–333 and 345–691, respectively, in human
lactoferrin). These N- and C-lobes are joined by a three-turn
-helix (residues 334–344 in human lactoferrin). Each lobe
is then further subdivided into two domains (NI and NII and
CI and CII) and contains a single iron-binding site, located
in a deep cleft between the domains. Apart from the con-
necting helix, interactions between the two lobes involve
primarily the domains NI and CI, which interact via a
number of hydrophobic side chains. These give a hydro-
phobic cushion between the lobes, which may both explain
the strong tendency of separated half-molecules to associate
and also allow some relative movement of the two lobes.
The metal ion in both lobes is coordinated by four protein
side chains. In the N-lobe of human lactoferrin (Figs. 1 and
2 A), this is via the phenolate oxygens of Tyr-92 and
Tyr-192, the imidazole nitrogen of His-253, and the carbox-
ylate oxygen of Asp-60 (Fig. 2 B). The metal coordination
is completed by the carbonate ion, which is bound in a
bidentate fashion to give a six-coordinate, distorted octahe-
dral geometry around the metal. Although the iron-binding
site in each lobe is buried deep within the protein, some
10–12 Å beneath the molecular surface, its environment is
distinctly hydrophilic. The two-domain structure, with the
binding site in the cleft between the domains, provides a
mechanism for binding and release; a hinge in the backbone
strands behind the iron site would allow the cleft to be
opened or closed over the bound substrate by relative move-
ment of the domains (Gerstein et al., 1993). An important
part of this design is that the metal takes its ligands from
four different parts of the structure, the Asp residue from the
first domain, one Tyr residue from the second domain, and
the other two ligands from the two backbone strands.
The x-ray crystal structure of human apo-lactoferrin
(Anderson et al., 1990) shows that iron and carbonate re-
moval produces a very large conformational change in the
N-terminal half of the molecule (see Fig. 1). The NII do-
main has rotated by 54°, relative to the NI domain, about an
FIGURE 1 Main chain worm representations produced using GRASP
(Nicholls et al., 1993) for the open iron-free and closed iron-loaded forms
of the N-terminal half-molecule of human lactoferrin. The positions of the
iron and carbonate in the closed form are indicated.
FIGURE 2 (A) Main chain worm representation of the N-terminal half-
molecule of human ferri-lactoferrin with some -carbon positions indi-
cated to assist in locating the positions of residues discussed in the text. (B)
The iron-binding site of the N-lobe of human lactoferrin. The geometry of
the complex is distorted octahedral.
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axis near the back of the iron site, such that the N-lobe
binding cleft is opened wide. This results in the exposure of
a number of residues previously buried in the interdomain
cleft, including several basic side chains. It also results in
the separation of the potential iron ligands, such that the two
tyrosine residues remain with domain NII (which also car-
ries the anion site) whereas the histidine and aspartate
ligands remain with domain NI. The conformational change
is essentially a rigid-body movement of the whole NII
domain and is achieved by flexing of the hinge region.
Various physical studies, including hydrodynamic measure-
ments (Rossenau-Motreff et al., 1971) and small-angle x-
ray and neutron scattering studies (Kilar and Simon, 1985;
Vigh et al., 1989; Grossman et al., 1992, 1993) support such
a conformational change and show that the molecule is
markedly more compact when iron is bound.
Iron release can be triggered by a reduced pH, with
release from serum transferrin beginning at a pH of 6.0 and
being complete at a pH of 4.0, whereas for lactoferrin,
release occurs in the pH range from 4.0 to 2.5 (Mazurier and
Spik, 1980). The conventional view has been that, in vivo,
iron-loaded transferrin binds to its cellular receptor, is in-
ternalized, releases its iron at the lower intravesicular pH
(5.5), and is then recycled to the outside of the cell as
apoprotein (for recent reviews see Qian and Tang, 1995; De
Silva et al., 1996). The only experimentally determined pKa
values that have been reported for transferrins, however, are
for some of the histidine residues in half-molecules of
ovotransferrin (Woodworth et al., 1987) and for some of the
histidine residues in human serum apo-transferrin (Kubal et
al., 1994). No similar results are available for human lac-
toferrin, which also has a somewhat different distribution of
histidine residues. In the absence of experimentally deter-
mined pKa values for most of the titratable residues in
transferrins, we have used computational methods.
A mechanism for iron release has been proposed, involv-
ing a pH-sensitive dilysine trigger in the N-lobe of hen
ovotransferrin (Dewan et al., 1993) based on the crystal
structure in which an unusual interdomain interaction is
formed between the NZ atoms of Lys-209 and Lys-301,
which are 2.3 Å apart and which are also involved in
hydrogen-bonding interactions with the aromatic ring of a
tyrosine residue. The protein crystals were grown at pH 5.9
(i.e., well below the usual pKa 10 for a lysine side chain),
and it was suggested that the pKa of either one or both of
these residues lies below the pH of the structure determi-
nation and is, therefore, not positively charged and that
uptake of the Fe(III)-transferrin complex into an acidic
endosome via receptor-mediated endocytosis would result
in the protonation of both lysine residues. The close prox-
imity of the two resulting positive charges, and their loca-
tion on opposite domains of the N-lobe, might well be the
driving force that opens the two domains of the protein,
exposing the Fe(III) ion and facilitating its release.
Examination of the amino acid sequences of other trans-
ferrins indicated that similar pH-sensitive dilysine triggers
may be possible in the N-lobe, but not the C-lobe, of most
serum transferrins. Dilysine triggers are not possible in the
C-lobe of hen ovotransferrin or in either lobe of most
lactoferrins. Although Lys-301 is maintained in the human
lactoferrin structure, Arg-210 occupies a position similar to
that of Lys-209 of ovotransferrin. Lys-301 also forms a salt
bridge with Glu-216 and is 5 Å from Arg-210. As Glu-
216 and Lys-301 are on opposite domains, this salt bridge
would tend to hold the domains together. Clearly, if this
release mechanism is correct, then different release mech-
anisms must exist in different transferrins.
Gelb and Harris (1980) demonstrated that binding of
ferric iron and bicarbonate to human serum transferrin at pH
7.6 and 20 mM ionic strength resulted in the release of 3.1
H ions per bound metal ion, and binding of ferric iron and
bicarbonate to hen ovotransferrin over the pH range 7.5–9.5
and 20 mM ionic strength resulted in the release of 2.9 H
ions per bound metal. The conformational change illustrated
in Fig. 1 is assumed to accompany this process. Addition of
oxalate (C2O42) as the anion instead of bicarbonate
(HCO3) resulted in the similar release of approximately
three H ions per bound metal ion, and this was interpreted
as indicating that the bicarbonate was not deprotonated
upon binding. A growing number of x-ray crystal structures
of transferrins suggest that this conclusion was incorrect and
that the bicarbonate is most likely deprotonated to carbonate
(CO32) upon binding. It is possible that the binding of
oxalate (which is a larger anion than carbonate) promotes a
different pattern of deprotonation in the proteins. If one of
the H ions is released from the bicarbonate, then this
implies that there is a net release of approximately two H
ions from the transferrins. It is doubted that one can simply
attribute the release of the other two H ions to deprotona-
tion of the two binding-site tyrosine residues, which are
assumed to be in a deprotonated state when the iron is
bound.
We have used continuum electrostatic calculations to
generate titration curves for the two forms of human lacto-
ferrin. Comparison of the average protonation states of the
two forms of the protein at the same pH in the pH range
7.5–9.5 should yield a difference of approximately two
protons, the open iron-free form of the lactoferrin being
more highly protonated than the closed iron-loaded form.
Analysis of the titration curves of individual residues in the
two forms of the protein should then allow identification of
the residues responsible for this difference.
METHODS
Model building
Initial models were constructed using the suite of programs AMBER 4.1
(Pearlman et al., 1995). Atomic coordinates were obtained from the
Brookhaven Protein Databank for human ferri-lactoferrin (1lfg) and for
human apo-lactoferrin (1lfh). Given the size of the protein, the degree of
homology between the N-lobe and C-lobe and the fact that both have
iron-binding sites, it was decided to use half-molecules in these calcula-
tions. Residues 1–333 were used to represent the N-lobe half-molecule of
the protein. As coordinates for the first two residues of the protein are
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missing, it was considered preferable to place an acetyl blocking group at
the N terminus of the protein rather than have a titratable amino group in
an incorrect position. Similarly, the C terminus of the half-molecule was
artificially created, and it was thus considered preferable to add an N-
methyl blocking group at the C terminus rather than have a titratable
carboxylic acid group. Coordinates for the side-chain atoms of Arg-86 in
the ferri-lactoferrin structure were also missing, and these were built in by
the EDIT program of AMBER 4.1. An all-hydrogen-atom model was
employed and partial atomic charges were taken from the AMBER 4.1
1994 parameter set where possible.
The programs used in this work to calculate pKa values require that
coordinates are given for all titratable hydrogen atoms, so all titratable
residues in the protein had to be built into the models in their protonated
states. The coordinates for the non-hydrogen atoms of the C-terminal
blocking group were derived from the coordinates of residue 334. The
coordinates of the N-terminal blocking group, the Arg-86 side chain atoms
in ferri-lactoferrin and all of the hydrogen atoms, which were determined
by EDIT, were subjected to simultaneous energy minimization using the
belly option, which means that the positions of all other atoms were kept
frozen. 10 cycles of steepest descent were followed by conjugate gradient
minimization until an energy gradient tolerance of 0.01 kcal/mol Å was
reached. 1–4 electrostatic interactions were divided by 1.2 as recom-
mended for the 1994 parameters.
The pKa values have been experimentally determined for all of the
titratable residues of hen egg-white lysozyme, and so this protein provides
a good system to test the predictive power of the calculation scheme
presented herein. An all-atom model of hen egg-white lysozyme using the
AMBER 1994 parameters was therefore also built. Atomic coordinates
were obtained from the Brookhaven Protein Databank (2lzt). As no atomic
partial charges appropriate to a deprotonated N terminus or a protonated C
terminus have yet been calculated (see below), the termini of the protein
were maintained as nontitrating groups in their charged states. The posi-
tions of all hydrogen atoms were energy minimized as described for
lactoferrin.
Electrostatic calculations
Electrostatic calculations were performed using version 1.1.3 of MEAD,
macroscopic electrostatics with atomic detail (Bashford, 1993). The elec-
trostatic potential in and around a molecule in solvent is assumed to be
governed by the linearized Poisson-Boltzmann equation:
rr	 2rr4	
r (1)
where (r) is the electrostatic potential at position r due to the charge
distribution 
, which has the form of point charges on atom centers;  is the
dielectric constant, which took the value s 
 80 in the solvent-accessible
region and m 
 4 in the molecular interior; and  is a modified Debye-
Hu¨ckel parameter, which accounts for counterion screening in the solvent.
The solvent-accessible region was defined as the volume that could be
swept out by a spherical probe of radius 1.4 Å without overlapping any
atomic radii of the molecule; what remained was defined as the molecular
interior. A finite difference approach was employed to find the electrostatic
potential  in the model system. A two-step focusing method was em-
ployed using an initial 813 grid with a 1-Å spacing centered on the
geometrical center of the protein, followed by a 813 grid with a 0.25-Å
spacing centered on the titrating residues. Calculations for the model
compounds adopted the same approach but with a grid dimension of 613.
Calculation of additional atomic partial charges
As the AMBER 1994 atomic partial charge set for amino acids in proteins
does not include values for the deprotonated forms of tyrosine, lysine, or
arginine residues, it was necessary to calculate appropriate values, which
was achieved by following as closely as possible the AMBER methodol-
ogy. Models of these three residues in their deprotonated forms with acetyl
and N-methyl blocking groups were built using QUANTA (Molecular
Simulations Inc., 1986, 1992). Ab initio geometry optimizations were then
performed by the unrestricted Hartree-Fock self-consistent field method at
the 6–31G* level using the suite of quantum chemistry programs CAD-
PAC 6 (Amos et al., 1995). A distributed multipole analysis (DMA)
representation to rank 5 of the potential surrounding each geometry-
optimized structure was then generated and imported into the program
ORIENT (Stone, 1990). ORIENT was used to generate potential surfaces
at 1.4, 1.6, 1.8, and 2.0 times the Van der Waals radii. Atomic partial
charges were fitted to these surfaces using the RESP program from AM-
BER 4.1 in a two-stage fitting procedure as described for the derivation of
the AMBER 1994 atomic partial charges (Pearlman et al., 1995). When
entering these newly calculated charge parameters (Fig. 3, A and B) into the
AMBER database, standard atomic partial charges were assumed for the
main-chain atoms whereas small adjustments were made to the calculated
charges to maintain the correct net charge.
Ab initio calculations were also undertaken on a pseudo-molecule
representing the active site as a whole using the atomic coordinates of the
iron, carbonate, and four binding-site residues. The protein residues were
truncated by methyl groups at their -carbon atoms using the molecular
modeling package QUANTA. An unrestricted Hartree-Fock self-consistent
field calculation was then performed for this pseudo-molecule at the
6–31G* level (STO3G for the iron atom) using CADPAC 6. The pseudo-
molecule was given a net charge of 2e and the iron was assumed to be
in the high spin state and so the multiplicity was set to 6. A distributed
multipole analysis (DMA) representation to rank 5 of the potential sur-
rounding the pseudo-molecule was generated and imported into the pro-
gram ORIENT. RESP charges were then calculated as described above.
The two tyrosine residues were constrained to be equivalent, and standard
atomic partial charges were assumed for the main-chain atoms with small
adjustments to the calculated charges being made to maintain the correct
net charge (Fig. 3 A).
pKa calculations
The fractional degree of protonation, fi, of any ionizable group, i, is given
by
lnfi/1 fi	 2.3pKai pH (2)
The relationship between the pKa of an isolated amino acid in solution,
pKai0, and the pKa of the same group in a protein with a single titratable site,
pKaiint (the intrinsic pKa), is given by
pKaiint pKai0  iGienv/2.3kBT (3)
where Gienv is the change in electrostatic energy of ionizing the group in
the protein environment relative to solution. (i) 
 1 or 1 for an acidic
or basic group, respectively, and KB and T are the Boltzmann constant and
absolute temperature, respectively. The Gienv can be calculated by taking
the difference between the difference in free energy of the group in the
unprotonated state with its protein environment relative to the reference
state in solution, Gienv(A) and that of the corresponding term for the same
group in the protonated state, Gienv(AH).
Each of these terms can be considered as being due to two contributions,
namely, the difference in reaction field energy in the isolated state and in
the protein and the contribution of the permanent dipoles and any other
pH-independent electric field in the protein. The latter would include, for
example, the effects of bound ions and water molecules and the distribution
of electrostatic potential on the other residues in the protein in their
uncharged states. The reaction field term is just the contribution of those
parts of the system treated as a dielectric continuum. These calculations
were implemented using the Multiflex program of MEAD with the AM-
BER 4.1 1994 charge and atomic radii parameter sets.
When the protein has more than one titratable group, the mutual
charge-charge interactions at the titrating site become pH dependent. pKai
is now obtained by determining the pH at which the group i is 50%
protonated. This is done by calculating a titration curve for the entire
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system. In most cases, the pKa of group i can now be written in the form
pKai pKaiint pKaittr (4)
The last term in Eq. 4 is simply due to charge-charge interactions between
titratable groups.
In principle, the titration curve of the system can be obtained from a
statistical mechanical average over the 2N states that arise from the N
ionizable sites; however, this becomes impractical as N reaches several tens
of titratable groups. An alternative approach uses a Monte Carlo sampling
technique, which has been implemented in the program Monti (Beroza et
al., 1991). At each step of 0.1 pH units, 1000 full steps of Monte Carlo
were performed followed by 5000 reduced steps in which the residues most
likely to remain fully protonated or deprotonated were omitted from the
sampling (tolerance
 1 106 proton). Increasing the number of reduced
steps from 4,000 to 10,000 in blocks of 1,000 indicated that the calculation
converged after 5,000 steps to within 0.1 pK unit with most values being
within 0.02 pK unit (results not shown).
Lysozyme
These calculations were performed at 293 K with an ionic strength of 150
mM to allow direct comparison with the results of Antosiewicz et al.
(1996). For the histidine residue, atom NE2 was assumed to be deproto-
natable. Antosiewicz et al. (1996) reported that the computed pKa of
residue Glu-35 was sensitive to the details of proton placement. When they
allowed this residue to be protonated on the alternative carboxylic oxygen
atom (OE1) rather than the default choice (OE2), they found a significant
improvement in the calculated pKa value for this residue compared with the
experimental value. Therefore, we also repeated our calculations with both
protonation states for this residue. The results of our test calculations on
this system (Table 1) show that we obtain similar overall agreement with
experimental pKa values as Antosiewicz et al., i.e., a root mean squared
deviation (rmsd) of 2.2 pK units, and we also see the effect of the
alternative protonation sites for Glu-35. If, however, the problematic res-
idue Tyr-53 is excluded from the analysis, then our rmsd becomes 1.7 pK
units compared with 1.0 pK units for Antosiewicz et al., suggesting that our
parameters and methods may give a somewhat poorer agreement with
experiment.
Lactoferrin
We adopted the same overall procedure as used successfully for lysozyme.
For the four histidine residues, atom NE2 was assumed to be the depro-
tonatable atom by inspection of the environments of these residues in the
x-ray crystal structures. In simulating the experimental conditions of Gelb
and Harris (1980), the calculations were carried out at 294 K and with an
ionic strength of 20 mM. Calculations were also repeated at an ionic
strength of 145 mM and at 310 K to simulate physiological conditions. The
four active-site binding residues were found to be fully deprotonated at a
pH below which any of the other residues in the protein started to titrate,
due to the proximity of the 3 background charge associated with the iron.
Therefore, these residues were regarded as nontitrating and contributing
only to the background charges. The pKa values were recalculated for
ferri-lactoferrin with the four binding-site residues held in their deproto-
nated states. A further refinement was then made where the atomic partial
charges on the deprotonated binding site residues were adjusted to attempt
to create a more realistic model of the chemical nature of iron binding. The
pKa values for the ferri-lactoferrin were then calculated again with this
modification.
RESULTS
The pKa values for titratable residues in the N-terminal
half-molecule of apo-lactoferrin have been calculated. The
calculation has been repeated for the iron-bound form with
FIGURE 3 (A) Atomic partial charges used in modeling the iron-binding
site, before and after adjustment to account for interactions between the
iron and its ligands. The atomic partial charges for the deprotonated form
of a tyrosine residue used in the pKa determinations are also shown. All
main chain atoms are assigned standard AMBER 4.1 atomic partial charges
and so are not shown. The two tyrosine residues in the binding site were
constrained to be equivalent and so only one is shown. (B) Atomic partial
charges assigned to the side chain atoms of the neutral forms of arginine
and lysine residues.
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three different models of the binding site. The data are
presented for individual residues in Table 2, and the accu-
mulated effect for the whole N-lobe can be seen in Fig. 4 A
for both apo and iron-bound (model ferri(c)) forms. In Table
2 we have listed only those residues for which there is a 2
pK unit difference between any two models. We have also
highlighted the residues involved directly in iron binding,
i.e., Asp-60, Tyr-92, Tyr-192, and His-253.
In apo-lactoferrin, with the exception of Tyr-192, all of
the tyrosine residues have substantially elevated pKa values.
The tyrosine residues Tyr-82, Tyr-189, and Tyr-319 start
with elevated pKaint values due in most part to their low
solvent exposure. Charges on anionic titratable residues
contribute further to the elevation of their pKa values, e.g.,
Glu-80, which is very close to Tyr-82. As the pH increases,
the negatively charged, deprotonated form of the tyrosine
residues is further disfavored by the increasing net negative
charge on the protein. The intrinsic pKa of His-116 is also
substantially lowered by the buried position of the residue in
the protein, and the pKa is shifted further downwards by the
proximity of Arg-121.
There appears to be a competition for protonation be-
tween the two iron-binding ligands Tyr-92 and Tyr-192.
Both residues start with fairly low pKaint values (8.1 and
7.0), due in most part to the environment of background
charges. Each residue contributes substantially to the back-
ground charges experienced by the other, and there may be
TABLE 1 Comparison of PKa values for hen egg-white
lysozyme
Residue PROTA* PROTA# PROTB* PROTB# Experimental
N terminus 5.6 5.6
Lys-1 9.1 9.1 10.1 10.1 10.6
Arg-5 10.5 10.5 12.8 12.8
Glu-7 2.8 2.8 2.9 2.8 2.9
Lys-13 10.3 10.3 10.7 10.7 10.3
Arg-14 12.5 12.4 12.4 12.4
His-15 5.3 5.3 5.1 5.1 5.4
Asp-18 1.9 1.9 2.7 2.7 2.7
Tyr-20 13.2 13.1 12.4 12.4 10.3
Arg-21 12.3 12.3 12.7 12.7
Tyr-23 11.6 11.6 9.7 9.7 9.8
Lys-33 12.8 12.9 10.9 10.9 10.4
Glu-35 3.9 4.8 3.5 5.6 6.2
Arg-45 11.8 11.8 12.2 12.2
Asp-48 0.6 0.7 1.5 1.5 1.6
Asp-52 2.0 1.8 4.3 3.6 3.7
Tyr-53 18.0 18.0 20.5 20.5 12.1
Arg-61 12.1 12.1 13.8 13.7
Asp-66 5.8 5.8 1.9 1.9 0.9
Arg-68 15.3 15.3 13.0 13.0
Arg-73 12.7 12.7 12.5 12.5
Asp-87 2.2 2.2 2.4 2.4 2.1
Lys-96 11.6 11.6 13.6 13.6 10.7
Lys-97 11.4 11.4 11.2 11.2 10.1
Asp-101 4.4 4.3 4.4 4.4 4.1
Arg-112 11.7 11.6 11.2 11.2
Arg-114 12.9 12.9 13.3 13.3
Lys-116 9.3 9.3 9.3 9.3 10.2
Asp-119 3.0 3.0 3.7 3.7 3.2
Arg-125 13.3 13.3 12.9 12.9
Arg-128 12.1 12.1 12.2 12.2
C terminus 3.1 3.1 2.8
rmsd 2.2 2.2 2.2 2.1
Comparison of the pKa values calculated for hen egg-white lysozyme
(PROTA) with those determined by experiment and with the computed
values reported by Antosiewicz et al. (1996) (PROTB). The final line of the
table provides the cumulative rmsd of the computed values from the
available experimental values.
*Results when all default protonation sites were used.
#Results when OE1 of Glu-35 was treated as the protonatable atom.
TABLE 2 pKa values calculated for apo and ferri forms of
the half-molecule of lactoferrin
Residue Apo form
Ferri form
a b c
Glu-15 0.4 2.7 3.0 4.1
Arg-39 10.2 13.1 13.0 13.1
Asp-55 4.4 6.7 6.8 6.9
Asp-60* 2.2 34.2
Tyr-65 13.9 14.1 12.0 12.4
Glu-66 4.2 1.2 1.3 1.6
Arg-75 15.1 18.3 18.2 18.2
Glu-80 4.9 7.2 6.2 1.7
Tyr-82 31.2 38.5 39.2 32.8
Arg-89 22.2 17.3 17.8 15.4
His-91 3.4 0.9 0.7 0.1
Tyr-92* 18.7 16.0
Tyr-93 15.7 16.2 16.0 17.9
Lys-100 11.3 14.3 14.3 14.3
His-116 8.5 1.4 1.3 0.5
Arg-121 8.9 27.7 27.0 28.1
Arg-151 15.2 17.6 17.6 17.6
Tyr-189 23.5 16.9 16.9 16.9
Tyr-192* 1.4 31.0
Lys-197 13.3 23.2 23.2 23.2
Asp-201 0.1 2.4 2.3 2.4
Arg-210 16.7 23.1 22.1 42.0
Glu-216 2.7 2.8 1.7 2.4
Asp-217 6.2 10.5 10.0 10.0
Lys-237 9.3 14.9 14.9 14.9
Lys-243 10.9 10.2 10.1 7.7
His-246 2.1 4.2 4.2 4.4
His-253* 6.3 52.9
Lys-277 6.6 11.0 11.0 11.0
Lys-280 9.8 12.1 12.1 12.1
Lys-282 13.9 7.4 7.4 7.5
Lys-285 10.0 0.3 0.3 0.3
Lys-296 11.9 19.9 19.9 19.9
Asp-297 3.3 10.6 11.6 10.4
Lys-301 14.6 34.6 34.9 34.8
Asp-302 1.3 5.4 5.6 5.8
Tyr-319 20.6 25.3 24.9 24.7
Tyr-324 15.0 7.2 16.7 20.6
(Lys-28) 9.3 8.9 8.9 8.9
Only those residues are listed for which there is a 2 pK unit difference
between any two models, except for residue Lys-28, which is also referred
to in the text. The results of using three models of the ferri form of the
binding-site residues are shown: a, with binding site residues titrating; b,
with the binding-site residues nontitrating and held in their deprotonated
states; and c, same as b but with atomic partial charges adjusted to reflect
the chemistry of the metal ion complex. The experimental conditions of
Gelb and Harris (1980) were used (temperature 
 294 K; ionic strength 

20 mM).
*Binding-site residues.
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overcrowding of atoms when both residues are protonated.
The proximity of Glu-212, however, tends to elevate the
pKa of Tyr-92 whereas the proximity of two arginine resi-
dues, Arg-121 and Arg-210, tends to keep the pKa of
Tyr-192 at a low level. These interactions tip the balance in
favor of Tyr-192 being more readily deprotonated, and the
resulting net negative charge on this residue then drives the
pKa of Tyr-92 even higher. The pKaint of Lys-277 is low
(7.6) due to its buried position in the protein. Electrostatic
interactions with other charged residues are weak, but the
pKa is kept low due to the residue being surrounded by more
cationic residues (Arg-272, Lys-282, Arg-30, and Lys-18)
than anionic residues (Glu-276).
The transition from apo-lactoferrin to the model of ferri-
lactoferrin with titrating binding site residues (ferri(a)) is
accompanied by some dramatic shifts in pKa values (Table
2). The pKa values of the binding-site residues are all
obviously predicted to be massively lowered by the prox-
imity of the 3 charge on the iron atom. Lys-277 becomes
more readily protonated because the solvent exposure of the
residue is increased by the conformational change. Asp-217
has a fairly high pKaint (5.9) in the apo-lactoferrin structure
due to both partial burial in the protein and adverse inter-
actions with the background electrostatic potential. This
situation is exacerbated in the ferri-lactoferrin structure by
increases in both factors such that the pKaint becomes 9.5.
Lys-285 is predicted to be deprotonated at pH 7.4 due to the
partial burial of the residue in the protein and its movement
toward the positively charged residue Lys-28. The lower
pKaint of Lys-285 compared with that of Lys-28 ensures that
Lys-285 is the one that is deprotonated more readily.
The pKa of Tyr-324 is predicted to be substantially low-
ered in the model with titrating binding-site residues but not
in the other models. This leads to the difference between
models ferri(a) and ferri(b) in the predicted release of H
ions. The effect of this stage in the refinement of the model
building is to worsen the apparent agreement with experiment.
In model ferri(a), Tyr-324 has a pKaint of 0.7 due to the
background charge of 3 associated with the iron atom. In
model ferri(b) Tyr-324 has a pKaint of 13.9 as the net nega-
tive charges on three of the binding-site residues are now
also background charges and Asp-60 and Tyr-92 are closer
to Tyr-324 than the iron atom is. In model ferri(a), the
negative charges on the binding-site residues have their
effect as titrating residues and result in a pKa of 7.2 for
Tyr-324. The much higher pKa of 16.7 when model ferri(b)
is assumed results from the fact that the phenyl hydrogen
atom in Tyr-324 adopts a position such that it donates to a
hydrogen bond between this residue and the hydroxyl oxy-
gen atom of Thr-122. In model ferri(a), this does not happen
as in this case the binding-site residue Asp-60 is protonated
and this additional hydrogen atom adopts a position such
that it now donates to a hydrogen bond with the hydroxyl
oxygen atom of Thr-122 and the hydroxyl hydrogen atom of
Thr-122 now becomes the hydrogen donor in a hydrogen
bond with the phenyl oxygen atom Tyr-324. The result is
that the phenyl hydrogen atom in Tyr-324 is forced to adopt
a much less favorable position in model ferri(a) due to an
extra hydrogen atom on residue Asp-60, which is very
unlikely to be there in any realistic protonation state of
ferri-lactoferrin. Model ferri(b) is thus assumed to be a
better model as its fully protonated state is closer to what is
assumed to be the protonation state of the protein over the
experimental range 7.5–9.5 and at the physiological pH of
7.4.
A few quite large pKa shifts are seen in residues close to
the binding site with the transition from model ferri(b) to
model ferri(c). These are due to the changes in the back-
ground charges in the binding-site residues contributing to
shifts in the pKaint values of residues. The downward shift in
the pKa of Lys-243 is the main reason for the difference
between models ferri(b) and ferri(c) in the predicted release
of H ions and for the restoration of a good agreement with
experimental results comparable with that of model ferri(a).
Using model ferri(b), the pKaint of Lys-243 is 10.4, but using
model ferri(c), it is 8.2. Lys-243 is in fact quite distant from
the iron-binding site (Fe(III)  NZ distance 
 16.41 Å),
and the difference in pKaint is due to a difference in the
position adopted by the phenyl hydrogen atom on Tyr-93. In
FIGURE 4 (A) The calculated titration curves of the N-terminal half-
molecules of human apo- and ferri-lactoferrin over the pH range 7.5–9.5.
The mean protonation is the mean number of titratable hydrogen atoms that
are predicted to remain on the protein at a given pH. (B) The predicted
mean shift in protonation of the N-terminal half-molecule of human lac-
toferrin over the pH range 7.5–9.5 as a result of the transition from the apo
to the ferri form of the protein.
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model ferri(c), the phenyl hydrogen atom on Tyr-93 is much
closer to the NZ atom of Lys-243 (1.972 Å compared with
3.062 Å) and thus destabilizes a positive charge on this
residue. The difference in the optimal position adopted by
the phenyl hydrogen atom of Tyr-93 must be a long-range
effect of the redistribution of charge at the iron-binding site.
The massive pKa shift for Arg-210 in the transition from
model ferri(b) to model ferri(c) is due to the redistribution
of electrostatic potential in the binding-site residues; i.e., the
positive charge on Arg-210 helps stabilize the redistribution
of electrostatic potential that occurs when iron binds, and its
presence in that position in the protein is thus predicted to
favor iron binding. Model ferri(c) is assumed to be the best
model for ferri-lactoferrin because the four unnecessary
hydrogen atoms on the binding-site residues are omitted
from the calculation scheme, thus leaving more space for
other titratable hydrogen atoms to find their optimal posi-
tion and because the chemical interaction between the iron
and its ligands is fully accounted for. Polarizability of the
protein is modeled by the dielectric constant of 4, but this
may be inadequate to account for the polarization of its
ligands by the ferric iron atom.
Titration curves were prepared for the half-molecule of
apo-lactoferrin and for the three model forms of the half-
molecule of ferri-lactoferrin to allow comparison of the
calculated results with the experimental results of Gelb and
Harris (1980). Comparison of the titration curves for the apo
and ferri forms of the protein revealed the predicted number
of H ions released in the experimental pH range 7.5–9.5
(Table 3). The titration curves for apo-lactoferrin and the
most accurate model of ferri-lactoferrin (ferri(c)) are shown
in Fig. 4 A. The difference between them is highlighted in
Fig. 4 B. This difference can be decomposed into the con-
tributions made by individual residues by preparing titration
curves for each residue in the two forms of the protein and
calculating the difference between them as for the full
protein. An example of the titration curves calculated for
one residue (Lys-285) is shown in Fig. 5 A, and the differ-
ence between these two curves and the differences for the
other twelve residues that make the major contribution to
the overall difference for the protein in this pH range are
shown in Fig. 5 B. The characteristic sigmoidal shape of the
titration curves for Lys-285 is typical of those calculated for
all of the residues in this study. Note that titration of the
residue extends over the fairly wide pH range of approxi-
mately 4 units.
When protonation state calculations were performed with
the simulation of physiological conditions (temperature 

310 K; ionic strength 
 145 mM) and model ferri(c) of
ferri-lactoferrin, the release of 1.1 H ions was predicted
upon the transition from apo- to ferri-lactoferrin (2.1 if the
bicarbonate is assumed to be deprotonated also). The cal-
culated pKa values varied to a small degree from those
shown in Table 2, which were calculated assuming the
experimental conditions of Gelb and Harris (1980). Table 4
shows the values calculated for those residues that are
assumed to be predominantly in different protonation states
at pH 7.4.
The work of Demchuk and Wade (1996) suggests that
computed pKa values are sensitive to the value chosen for
the protein dielectric constant (p). Higher values can,
through scaling electrostatic interactions, compensate for
features that are not explicitly present in the model, such as
dynamic motions. All calculations have been repeated with
p values of 10 and 20. For the model of lysozyme with
TABLE 3 Predicted number H ions released for the three
model forms of ferri-lactoferrin
pH
Ferri
a b c
7.6 1.5 (2.5) 0.9 (1.9) 1.3 (2.3)
7.5–9.5 2.0 (3.0) 1.3 (2.3) 1.9 (2.9)
The pH range shown allows comparison with the experimental results of
Gelb and Harris (1980), which showed the release of approximately three
H ions per bound metal ion. The values in parentheses include deproto-
nation of bicarbonate.
FIGURE 5 a. Calculated titration curves for Lys-285 in the N-terminal
half-molecules of human apo- and ferri-lactoferrin. The arrow indicates the
shift that is predicted to occur when the protein makes the transition from
the apo to the ferri form. (B) The shift in the mean protonation states of the
thirteen residues that are predicted to change in the pH range 7.5–9.5 when
the N-terminal half-molecule of human lactoferrin makes the transition
from the apo to the ferri form.
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default protonation sites, the rmsd of computed from exper-
imental pKa values is improved, to give a rmsd of 1.0 pK
units for both values of p, even when the result for the
problematic residue Tyr-53 is included. In fact, when an p
of 10 is assumed, a very realistic pKa of 11.7 is computed
for this residue (experimental pKa
 12.1). The rmsd values
of 1.0 pK unit are significantly better than that of 1.4 pK
unit attained when the null hypothesis is assumed; i.e., the
pKa values of amino acids in aqueous solution are assumed,
with the protein environment having no effect.
When p values of 10 and 20 are employed in the calcu-
lation of pKa values for the N-terminal half-molecule of
human lactoferrin, it is striking that the computed titration
curves, in the relevant pH range of 4–9.5, for the apo and
ferri (model ferri(c)) forms of the protein are not altered
significantly. Simulation of the experimental conditions of
Gelb and Harris (1980) results in the average net release of
H ions, in the pH range of 7.5–9.5, of 1.8 with p
 10 and
1.6 with p 
 20 (i.e., 2.8 and 2.6, respectively, assuming
deprotonation of bicarbonate upon binding). At pH 7.6, the
net release of H ions is 3.0 with p
 10 and 2.9 with p

20 (including deprotonation of bicarbonate). A very similar
degree of protonation in the transition under physiological
conditions from ferri-lactoferrin at pH 7.4 to apo-lactoferrin
at pH 4 is also predicted. A gain of 12.8 and 12.6 protons is
predicted using p 
 10 and p 
 20, respectively, com-
pared with our original calculation of 12.0 protons with
p 
 4. The net release of H ions under physiological
conditions at pH 7.4 due to iron and carbonate binding is a
little more sensitive, being 2.2 and 1.8 protons with p 
 10
and p 
 20, respectively, compared with 1.1 using p 
 4.
As expected, some sensitivity to the value chosen for p
is seen for individual residues. However, we find, when
simulating the experimental conditions of Gelb and Harris
(1980), that 69% of residues contributing to the release of
approximately two H ions with p 
 4 are the same as
those that contribute with p 
 10 and 62% with p 
 20.
The degree to which these remaining residues contribute, of
course, differs somewhat. The prediction of unusual proto-
nation states in the apo and ferri forms of the protein under
physiological conditions at pH 7.4 are also somewhat sen-
sitive to the choice of p. In the apo form, the pKa values of
Tyr-192 and Lys-277 are 7.0 and 9.0 with p 
 10 and 7.9
and 9.7 with p 
 20, compared with 1.4 and 6.6 with p 

4. In the ferri form, the pKa values of Asp-217 and Lys-285
are 5.3 and 6.4 with p 
 10 and 3.2 and 8.0 with p 
 20,
compared with 10.0 and 0.3 with p 
 4. The predictions of
the deprotonated states of Tyr-192 and Lys-285 are clearly
more robust.
DISCUSSION
Lactoferrin has been used here as a model for the transferrin
family as x-ray crystal structures are available for both the
open and closed forms of the protein. The fact that both
crystal forms of human lactoferrin were grown at pH 7.8
indicate that their protonation states should be reasonably
appropriate to the physiologically relevant pH of 7.4 and to
the experimental pH range (7.5–9.5) used by Gelb and
Harris (1980). Experimental evidence is available to support
the use of lactoferrin as a model for serum transferrin.
Chung and Raymond (1993) made a comparison of the
relative rates of ferric iron removal at pH 7.4 and 37°C from
human milk lactoferrin and human serum transferrin by a
synthetic triatecholate sequestering agent. Results indicated
that iron removal from lactoferrin proceeds by a mechanism
essentially the same as that for removal of iron from serum
transferrin. Day et al. (1992) have expressed an N-terminal
half-molecule (residues 1–333) of human lactoferrin from
cloned cDNA in baby hamster kidney cells. Crystals have
been grown, and a structure determination is awaited. Iron
release from the half-molecule occurred in the pH range
6.0–4.0 compared with 4.0–2.5 for native lactoferrin and
6.2–4.0 for transferrin. These results suggest that the more
facile release of iron from the half-molecule compared with
the native lactoferrin resulted from the absence of stabiliz-
ing contacts between the N- and C-terminal halves and that
the characteristic difference in pH stability between lacto-
ferrins and transferrins is due primarily to differences in
these interactions. This observation is interpreted as
strengthening the case for the use of the N-lobe of human
lactoferrin in this study. Not only are the contacts between
the N- and C-lobes limited, but moreover, these are com-
posed of mostly nontitratable residues.
El Hage Chahine and Pakdaman (1995) have studied the
in vitro kinetics of iron release from human serum holo-
transferrin and have invoked a mechanism that is indepen-
dent of the nature and concentration of competing ligands
and of receptor binding. It is controlled by a slow proton
transfer attributed to a rate-limiting slow proton gain by a
protein ligand subsequent to a fast decarbonation of the
N-site. Such a mechanism offers hope that simulation of
iron release can be achieved with a relatively simple model,
without the need to explicitly represent a competing ligand
or receptor binding.
In reproducing the experimental results of Gelb and Har-
ris (1980), the calculations were intended to identify resi-
dues that are likely to have different protonation states in the
two conformations of the half-molecule of human lactofer-
rin at the same pH. A few quite extreme pKa shifts in the
TABLE 4 Comparison of the calculated pKa values for the
N-terminal half-molecules of human apo and ferri-lactoferrin
under simulated physiological conditions
Residue Apo Ferri(c)
Tyr-92 17.6 7.4
Asp-217 6.3 9.3
Lys-277 7.1 11.0
Lys-285 10.1 1.1
The model form of the ferri-lactoferrin is the same as model c in Table 2.
Only those residues for which a shift in the pKa value from one side of pH
7.4 to the other is predicted are shown. Temperature 
 310 K; ionic
strength 
 145 mM.
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two structures of lactoferrin were predicted, and these are
most likely artifacts of the method of solution of the mul-
tiple titration site problem for this large protein. Many of
these are irrelevant to this investigation as the same proto-
nation state in the pH range 7.5–9.5 is predicted in both
structures.
Atypical predominant protonation states predicted to be
found in apo-lactoferrin in the pH range 7.5–9.5 are for the
deprotonated residues Tyr-192 and Lys-277, and for ferri-
lactoferrin, these are for the deprotonated residues Tyr-92,
Tyr-192, Lys 243, Lys-282, and Lys-285 together with a
protonated Asp-217. Although Fig. 5 B shows that 13 res-
idues are predicted to contribute to the observed net release
of approximately two H ions from the protein upon bind-
ing of iron and carbonate and the conformational change,
the major contributions can clearly be seen to be due to the
deprotonation of residues Tyr-92, Lys-243, Lys-282, and
Lys-285 together with the protonation of residues Asp-217
and Lys-277. The positions of these residues in the protein
structure are shown in Fig. 6. The apparent agreement with
the experimentally observed release of H ions is reassur-
ing. However, with the exception of Tyr-92, the other five
residues all have computed pKa values in the apo and/or
ferri forms, which are close to the experimental pH range,
and given the estimated accuracy of the calculations em-
ployed here (rmsd 
 2.2 pK units for lysozyme), some
caution should be exercised in the interpretation of these
results. The method does not allow precise quantification of
the relative contributions of individual residues.
Calculations were also undertaken with physiologically
relevant conditions. If one assumes that the most probable
protonation state corresponds to the biologically significant
form of the protein, then, at pH 7.4 it is necessary only to
ask for which residues the pKa has shifted from one side of
7.4 to the other as a consequence of iron and carbonate
binding and the conformational change. In Table 3 it can be
seen that these residues are Tyr-92, Asp-217, Lys-277, and
Lys-285. Lys-243 and Lys-282 are predicted to be much
less likely to deprotonate if iron binding occurs under phys-
iological conditions at pH 7.4. In response to iron and
carbonate binding and the conformational change under
physiological conditions, Tyr-92 and Lys-285 are predicted
to become deprotonated and Asp-217 and Lys-277 to be-
come protonated. If Tyr-192 were already deprotonated
before iron binding, this could contribute to priming the
binding site.
The suggestion that the proximity of Lys-28 to Lys-285
in the ferri-lactoferrin structure is the primary reason for the
downward shift in the pKa value for Lys-285 is reminiscent
of the dilysine trigger mechanism proposed by Dewan et al.
(1993) and discussed in the Introduction. In this case, how-
ever, the two lysine residues are not located on opposing
domains but are both on the same domain and quite distant
from the binding-site cleft. With 4 Å between the two NZ
atoms in the crystal structure, these lysine residues also do
not appear to be hydrogen bonded to each other.
The crystal structures indicate that, upon iron binding, the
loop where Lys-285 is located moves slightly toward the
-helix where Lys-28 is located. The major difference,
however, is in the moving together of the side chains of
these residues. It is expected that during the pH-induced
release of iron from transferrins there is some mechanism in
operation to communicate changes in the pH of the solvent
to the interior of the protein. The position of Lys-28 and
Lys-285 near the surface of the protein make these residues
candidates for involvement in such a mechanism. The struc-
tural changes in this region do, however, appear to be very
localized.
The position of Lys-285 on a surface exposed loop also
promotes speculation that it would be very suitable to form
part of a receptor-binding site. Not only would there be a
difference in the shape of this region of the protein surface
depending upon whether iron was bound or not but there
would also be a difference in the electrostatic potential at
the surface (Fig. 7). It is clear from analysis of crystallo-
graphic B-values that this is a highly mobile region in
lactoferrin. In apo-lactoferrin the average B-factor for Lys-
285 is 44.59 Å2 for main-chain atoms and 64.258 Å2 for
side-chain atoms, and these values are even higher in ferri-
lactoferrin.
A reduction in pH from pH 7.4 to 4 is required to fully
induce the release of iron from the N-lobe of human lacto-
ferrin (Day et al., 1992). Inspecting the pKa values calcu-
lated for apo-lactoferrin under physiological conditions in-
dicates that, in addition to the protonation of Tyr-92, Lys-
285, and presumably the carbonate, a number of other
residues become protonated, and these are listed in Table 5
(note that Lys-277 is predicted to be protonated at pH 7.4 in
ferri-lactoferrin). We have an indication of the protonation
states of ferri-lactoferrin at pH 7.4 and apo-lactoferrin at pH
4.0 that suggests that the protein gains 12.0 protons (and
presumably the carbonate gains one proton) during the
process of releasing the Fe(III) ion. Knowledge of these
FIGURE 6 The locations in the N-terminal half-molecule of human
ferri-lactoferrin of carbonate and the six residues that are predicted to make
a major contribution to the net release of three H ions upon metal and
carbonate binding. Residues Tyr-92, Lys-243, Lys-282, and Lys-285 and
bicarbonate are deprotonated whereas Asp-217 and Lys-277 are proton-
ated. The Fe(III) ion is represented by a sphere.
2756 Biophysical Journal Volume 74 June 1998
states at each end of the conformational change does not,
however, give a clear indication of the order of protonation
that occurs along the path of the conformational change.
The pKa values are conformation dependent, and the con-
formational change is, of course, a dynamic process.
The calculation of pKa values in proteins is a very chal-
lenging problem. The results of our test calculations on
lysozyme show that the performance of the programs and
parameters used here is comparable with that of those used
by Antosiewicz et al. (1996) who used a similar method
although with a different parameter set. Exclusion of the
problematic residue Tyr-53 does suggest, however, that our
results may be a little poorer. More accurate predictions
have recently been achieved for lysozyme by Sham et al.
(1997) and Demchuk and Wade (1996) using somewhat
different approaches. Much of the work presented here
represents preparation for subsequent molecular dynamics
(MD) simulations involving the N-lobe of human lactofer-
rin, and as such, a compromise has been struck between
accuracy and consistency between the continuum electro-
static and MD approaches.
There are a number of potential sources of error in the
calculation scheme presented here. Many extreme pKa shifts
are associated with the close proximity of charged residues,
which raises the possibility that inaccuracies in the solution
of the Poisson-Boltzmann equation at close range may
contribute to the size of the shifts.
A significant problem with the calculation scheme used
here is that a model structure of a protein is required that has
all the titratable hydrogen atoms in place. At the pH of the
crystal structure, such a degree of protonation is inappro-
priate (indeed, the low pH required to fully protonate all of
the titratable residues in a protein would most likely cause
chemical damage to and denaturation of the protein), and
thus there will always be some difficulty fitting in all of the
hydrogen atoms, which will be reflected in the calculated
pKa shifts. Demchuk and Wade (1996) have developed a
method that circumvents this problem and suggests a future
development of the work presented here. A consequent but
smaller source of error in the method used here is that the
surface of the protein is determined and fixed by the fully
protonated model of the protein and does not change in
shape when a surface residue is deprotonated.
Factors that are presently thought to be among the most
important in improving the accuracy of predicted pKa val-
ues in proteins are the inclusion of a detailed representation
of the redistribution of electrostatic potential that occurs in
a residue when its protonation state changes, the introduc-
tion of conformational flexibility into the model of the
protein (You and Bashford, 1995; Zhou and Vijayakumar,
1997), and the inclusion of a term that estimates the entropy
associated with first hydration shell solvent ordering (War-
wicker, 1997). A detailed charge model is used in the work
presented here. Antosiewicz et al. (1996) have shown that
the use of the commonly assumed value of p 
 4 works
well with a detailed charge model, and this value was
assumed in the main part of the work presented here.
Using higher values of p improved the results of our test
calculations on lysozyme. Different profiles of sensitivity of
FIGURE 7 The change in surface shape and surface electrostatic poten-
tial in the region of Lys-285 associated with the conformational change
accompanying iron and carbonate binding. Electrostatic potential is color
coded using a sliding scale (10KT to 10KT). Red represents
negative electrostatic potential, blue represents positive electrostatic po-
tential, and white is neutral.
TABLE 5 Residues in the N-terminal half-molecule of human
apo-lactoferrin that are predicted to have pKa values in the
range 7.4-4.0 under physiological conditions
Residue pKa
Glu-51 4.0
Glu-66 4.4
His-91 4.0
Glu-108 4.7
Asp-217 6.3
Glu-221 4.6
Glu-223 6.6
Glu-226 4.5
His-253 6.7
Lys-277 7.1
Asp-297 4.1
Temperature 
 310 K; ionic strength 
 145 mM.
Lee and Goodfellow Protonation States in Transferrins 2757
calculations to p are found for different proteins (Demchuk
and Wade, 1996), and the N-terminal half-molecule of
human lactoferrin is considerably larger than lysozyme,
which makes it difficult to draw any conclusions about the
most appropriate p to use with this protein. Demchuk and
Wade (1996) have also devised a method for predicting
what level of p is most suitable for each individual residue
in a protein, and this approach may prove useful in future
investigations of transferrins where experimentally deter-
mined pKa values are not available.
The calculated net effects of pH in the range 4–9.5 on the
N-terminal half-molecule of human lactoferrin, i.e., the ti-
tration curves and net gain or loss of protons, was insensi-
tive to p in the range 4–20. The protonation states of the
individual residues that contribute to these net effects were,
however, sensitive to p, and so we cannot at this stage
make very reliable predictions about individual shifts in pKa
values. Although it may be tempting to assume a higher
value for p, calculations will be less likely to identify those
key residues in proteins that are found experimentally to
have significantly shifted pKa values, and so unique and
interesting results may be overlooked in the drive to achieve
an overall improvement in one’s predictions.
Progress has been reported in the use of explicit solvent
models for the prediction of pKa shifts. Figuerido et al.
(1996) calculated pKa shifts for succinic acid by an explicit
solvent MD simulation that were very close to experimental
values. Accurate modeling of long-range effects using the
Ewald summation method was found to be necessary to
properly model the electrostatic shielding effect of the aque-
ous solvent. Although this approach would be highly com-
putationally expensive for calculating pKa shifts in proteins,
Figuerido et al. suggest that comparisons between explicit
and continuum solvent models can reveal differences that
have their true physical origin in the inherent molecularity
of the surrounding medium.
Baptista et al. (1997) have developed a method for in-
corporating pH effects into MD simulations with explicit
solvent that involves periodically updating the mean proto-
nation states of titrating residues according to a continuum
electrostatic calculation. This has been implemented in the
constant pH MD simulation of the small protein BPTI. It is
recognized that such an approach would be very valuable in
the study of transferrins, although application of the method
to such a large protein may, at present, be prohibitively
expensive computationally. As computers become faster it
may be possible to further develop this method such that the
mean protonation states are also calculated using the ex-
plicit solvent model.
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